ATE255165T1 - Rekombinantes mersacidin und verfahren zu seiner herstellung - Google Patents

Rekombinantes mersacidin und verfahren zu seiner herstellung

Info

Publication number
ATE255165T1
ATE255165T1 AT94114298T AT94114298T ATE255165T1 AT E255165 T1 ATE255165 T1 AT E255165T1 AT 94114298 T AT94114298 T AT 94114298T AT 94114298 T AT94114298 T AT 94114298T AT E255165 T1 ATE255165 T1 AT E255165T1
Authority
AT
Austria
Prior art keywords
mersacidine
recombinant
production
amino acid
premersacidin
Prior art date
Application number
AT94114298T
Other languages
English (en)
Inventor
Klaus-Peter Dr Koller
Hans Georg Prof Sahl
Gabriele Dr Bierbaum
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of ATE255165T1 publication Critical patent/ATE255165T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/32—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bacillus (G)

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT94114298T 1994-09-12 1994-09-12 Rekombinantes mersacidin und verfahren zu seiner herstellung ATE255165T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP94114298A EP0700998B1 (de) 1994-09-12 1994-09-12 Rekombinantes Mersacidin und Verfahren zu seiner Herstellung

Publications (1)

Publication Number Publication Date
ATE255165T1 true ATE255165T1 (de) 2003-12-15

Family

ID=8216276

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94114298T ATE255165T1 (de) 1994-09-12 1994-09-12 Rekombinantes mersacidin und verfahren zu seiner herstellung

Country Status (19)

Country Link
US (1) US5667991A (de)
EP (1) EP0700998B1 (de)
JP (1) JPH0898695A (de)
KR (1) KR100394289B1 (de)
CN (1) CN1149287C (de)
AT (1) ATE255165T1 (de)
AU (1) AU696450B2 (de)
CA (1) CA2157975C (de)
CZ (1) CZ285741B6 (de)
DE (1) DE69433357T2 (de)
DK (1) DK0700998T3 (de)
ES (1) ES2207636T3 (de)
FI (1) FI120100B (de)
HU (1) HU216619B (de)
IL (1) IL115242A0 (de)
NZ (1) NZ272960A (de)
PT (1) PT700998E (de)
RU (1) RU2198924C2 (de)
SI (1) SI9500270B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2369110C (en) * 1999-03-12 2010-11-23 Aware, Inc. Seamless rate adaptive multicarrier modulation system and protocols
US6778596B1 (en) * 1999-03-12 2004-08-17 Aware, Inc. Method and multi-carrier transceiver with stored application profiles for supporting multiple applications
US6861236B2 (en) 2002-05-24 2005-03-01 Applied Nanosystems B.V. Export and modification of (poly)peptides in the lantibiotic way
US7592308B2 (en) 2004-03-26 2009-09-22 Novacta Biosystems Limited F3W variants of the lantibiotic mersacidin and its use
GB0406870D0 (en) * 2004-03-26 2004-04-28 Novacta Biosystems Ltd Improvements relating to the production of lantibiotics
WO2007036706A1 (en) * 2005-09-27 2007-04-05 Novacta Biosystems Limited Variants of the lantibiotic mersacidin and their use
GB0600928D0 (en) 2006-01-17 2006-02-22 Novacta Biosystems Ltd Improvements relating to lantibiotics
GB0714029D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd Lantibiotic-based compounds having antimicrobial activity
GB0714030D0 (en) 2007-07-18 2007-08-29 Novacta Biosystems Ltd The use of type-B lantibiotic-based compounds having antimicrobial activity
EP2271665B1 (de) * 2008-04-02 2012-01-18 Sanofi Stark verbrückte peptide aus der actinomadura namibiensis
US20120053115A1 (en) * 2008-11-24 2012-03-01 Sentinella Pharmaceuticals, Inc. Lantibiotic Carboxyamide Derivatives With Enhanced Antibacterial Activity
WO2010082018A1 (en) 2009-01-14 2010-07-22 Novacta Biosystems Limited Deoxyactagardine derivatives
EA020733B1 (ru) 2009-02-04 2015-01-30 Новакта Биосистемс Лимитед Производные актагардина
GB201001688D0 (en) 2010-02-02 2010-03-17 Novacta Biosystems Ltd Compounds
GB201013513D0 (en) 2010-08-11 2010-09-22 Novacta Biosystems Ltd Formulations
CN106188253B (zh) * 2016-08-26 2020-08-18 上海交通大学 抗菌肽Lexapeptide及其制备方法和用途
BR112021015321A2 (pt) 2019-02-05 2021-10-05 Elanco Us Inc. Plataforma de dispensação viva, cassete de expressão, sequência de ácido nucleico, biomolécula, atividade anti-infecciosa, anticorpo, e, método para reduzir a colonização de um animal por uma bactéria patogênica
CN111235119B (zh) * 2020-03-05 2021-11-23 苏州十一方生物科技有限公司 一种融合抗菌蛋白的制备及应用
CN114457102B (zh) * 2022-02-24 2023-12-26 重庆市畜牧科学院 用于编码分泌型Mersacidin的基因表达盒及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5218101A (en) * 1988-07-05 1993-06-08 The University Of Maryland Leader sequence inducing a post-translational modification of polypeptides in bacteria, and gene therefor
IN167138B (de) * 1988-08-17 1990-09-01 Hoechst India

Also Published As

Publication number Publication date
JPH0898695A (ja) 1996-04-16
DK0700998T3 (da) 2004-03-29
SI9500270B (sl) 2002-02-28
US5667991A (en) 1997-09-16
IL115242A0 (en) 1995-12-31
SI9500270A (en) 1996-04-30
CA2157975C (en) 2008-11-18
HUT73800A (en) 1996-09-30
CN1149287C (zh) 2004-05-12
RU2198924C2 (ru) 2003-02-20
AU3055495A (en) 1996-03-28
PT700998E (pt) 2004-03-31
ES2207636T3 (es) 2004-06-01
CZ231895A3 (en) 1996-03-13
FI954220A (fi) 1996-03-13
NZ272960A (en) 1996-05-28
HU216619B (hu) 1999-07-28
KR100394289B1 (ko) 2003-10-22
CN1131192A (zh) 1996-09-18
DE69433357D1 (de) 2004-01-08
KR960010863A (ko) 1996-04-20
FI120100B (fi) 2009-06-30
DE69433357T2 (de) 2004-09-09
EP0700998B1 (de) 2003-11-26
FI954220A0 (fi) 1995-09-08
CA2157975A1 (en) 1996-03-13
HU9502643D0 (en) 1995-11-28
EP0700998A1 (de) 1996-03-13
AU696450B2 (en) 1998-09-10
CZ285741B6 (cs) 1999-10-13

Similar Documents

Publication Publication Date Title
ATE255165T1 (de) Rekombinantes mersacidin und verfahren zu seiner herstellung
ATE372383T1 (de) Verfahren zur herstellung von l-aminosäuren
ATE189476T1 (de) Material und verfahren zur stark vermehrter sekretion von aminosäuren
DE69231939D1 (de) Hybrid-Plasmid-Vektoren, die für Nitril-abbauende Enzyme kodierende Gene enthalten und Verfahren zur Herstellung von Amiden und Säuren
HUT68021A (en) Improved activating process of recombinant proteins
DE69530306D1 (de) Verfahren zur herstellung von l-lysin und l-glutaminsäure durch fermentation
DE69334152D1 (de) Verknüpftes D-Protein und Verfahren zur Identifizierung von Rezeptor Aktivität modulierenden Verbindungen
ATE97421T1 (de) Gentechnologisch hergestellter pankreatischer sekretorischer trypsininhibitor und seine varianten.
PT920501E (pt) Neuritina um neurogene
ATE165363T1 (de) Verfahren und mittel zur sortierung und bestimmung biologischer informationen
ATE264913T1 (de) Protease-resistente analoge des thrombomodulin
DE69430975D1 (de) Verfahren zur Herstellung von Proteinen
DE69126592D1 (de) Nicht-lineare Peptide, die hydropatisch komplementär zu bekannten Aminosäuresequenzen sind, Verfahren zur Herstellung und Verwendung davon
ATE281523T1 (de) Acarbose-biosynthesegene aus actinoplanes sp., verfahren zu ihrer isolierung sowie ihrer verwendung
PL320084A1 (en) Nucleic acids of amino acid type
DE69315730D1 (de) Verfahren zur Herstellung von Peptiden und neue Zwischenverbindungen dazu
DE3689084D1 (de) Verfahren zur in vitro-diagnose von boesartigen zellen aus dem verdauungstrakt.
DE59604613D1 (de) Verfahren zur herstellung von optisch aktiven alpha-aminosäuren und alpha-aminosäure-derivaten
DE69208652D1 (de) Verbessertes verfahren zur herstellung von chloressigsäure phenylester
DE69526462D1 (de) Verfahren zur Herstellung von Peptiden aus N-Carboxyanhydridaminosäuren
DE3865389D1 (de) Verfahren zur herstellung von l,l oder d,d oder racemat n6 benzyloxycarbonyl 2,6 diaminopimelinsaeuremonoamid.
IL98170A0 (en) Method for amino acid sequencing in internal regions of proteins

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0700998

Country of ref document: EP